Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 بازدیدها
administrator
07/14/23
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
نظری یافت نشد